BIPHASIC MESOTHELIOMA
Biphasic mesothelioma, is not an independent type of mesothelioma, but a combination of sarcomatoid and epithelioid. It is also a mixed bag of conditions in that it can take the good and bad aspects of the other two types, and almost 20-35% of all mesothelioma cases fall into either mixed or biphasic areas.
Biphasic Mesothelioma is the second most common type of mesothelioma cancer cell. Biphasic Mesothelioma does not have a unique cellular pattern unto itself; rather, Biphasic mesothelioma consists of a mixture of Epithelioid and Sarcomatoid mesothelioma cells.
Biphasic mesothelioma cancer cases have seen an increase in occurrence over the years. Whereas biphasic cancer was once seen in approximately 25% of all mesothelioma cases, it has recently been seen in approximately 46% to 63% of all cases.
The treatment options available for biphasic mesothelioma are the same as those used to combat epithelioid and sarcomatoid mesothelioma. Aside from having differing cellular appearances, the three mesothelioma subtypes also have differing average survival times. The mean survival time of biphasic mesothelioma cancer patients is the lowest of the three at six months.
Biphasic mesothelioma, is not an independent type of mesothelioma, but a combination of sarcomatoid and epithelioid. It is also a mixed bag of conditions in that it can take the good and bad aspects of the other two types, and almost 20-35% of all mesothelioma cases fall into either mixed or biphasic areas.
Biphasic Mesothelioma is the second most common type of mesothelioma cancer cell. Biphasic Mesothelioma does not have a unique cellular pattern unto itself; rather, Biphasic mesothelioma consists of a mixture of Epithelioid and Sarcomatoid mesothelioma cells.
Biphasic mesothelioma cancer cases have seen an increase in occurrence over the years. Whereas biphasic cancer was once seen in approximately 25% of all mesothelioma cases, it has recently been seen in approximately 46% to 63% of all cases.
The treatment options available for biphasic mesothelioma are the same as those used to combat epithelioid and sarcomatoid mesothelioma. Aside from having differing cellular appearances, the three mesothelioma subtypes also have differing average survival times. The mean survival time of biphasic mesothelioma cancer patients is the lowest of the three at six months.
Although the methods of treating Biphasic Mesothelioma cancer do not differ from those of treating epithelioid mesothelioma cancer or sarcomatoid mesothelioma cancer, the shorter average post-diagnostic survival time of Biphasic Mesothelioma cancer patients makes radical or more experimental treatments a more appealing option than standard treatment modalities.
